Botanical species · safety record

Cyclocarya paliurus

The EFSA Compendium of Botanicals holds 11 constituent measurements and 1 adverse-effect record for Cyclocarya paliurus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cyclocarya paliurus (Batalin) Iljinsk.

11Constituent measurements
1Safety records
8Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Cyclocarya paliurus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Leaf

What the records describe

Constituents measured

  • Saponins4
  • Coumarins2
  • Triterpene saponins2
  • Bergenin1
  • Gallic acid1
  • Sesquiterpene lactones1

Plant parts

  • Leaves8
  • Aerial part of plants4

Preparations

  • Solvent extraction6

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Sesquiterpene lactonesLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Triterpene saponinsLeavesUnspecifiedResolve DOI
BergeninLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
CoumarinsLeaves≤ 6.63 PercentUnspecifiedNo resolvable identifier
CoumarinsLeaves≥ 4.23 PercentUnspecifiedNo resolvable identifier
Gallic acidLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsAerial part of plantsSolvent extraction≥ 2.59 PercentUnspecifiedNo resolvable identifier
SaponinsLeaves≤ 10.99 PercentUnspecifiedNo resolvable identifier
SaponinsLeaves≥ 9.83 PercentUnspecifiedNo resolvable identifier
SaponinsAerial part of plantsSolvent extraction≤ 6.52 PercentUnspecifiedNo resolvable identifier
Triterpene saponinsAerial part of plantsSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveAerial part of plantsHouse mouse (as animal)Short-term toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kurihara, H., Fukami, H., Kusumoto, A., Toyoda, Y., Shibata, H., Matsui, Y., Asami, S., Tanaka, T. Hypoglycemic action of Cyclocarya paliurus (Batal.) Iljinskaja in normal and diabetic mice . Bioscience biotechnology and biochemistry, 2003, vol. 67, no. 4, p. 877-880.
  2. Zhang, Juan., Lu, Jin-cai., Xiao, Kai., Lu, Ting., Fan, Jun-wen., Zhang, Li-ming., Zhao, Jie., Yang, Jian-jun. Study on water-soluble constituents in leaves of Cyclocarya paliurus. Yaoxue shijian zazhi, 2007, p. 82-84.
  3. Chen, Jinhua., Huang, Jianan., Liu, Zhonghua. Analysis on chemical constituents in the leaves of Cyclocarya Paliurus. Shipin gongye keji, 2009, p. 159-160.
  4. Shu, Rengeng., Shu, Jicheng. Phenols of Cyclocarya paliurus. Zhongcaoyao, 2007, p. 507-508.
  5. Jiang, Xiang-hui., Yuan, Jing., Zhu, Jun-wei., Hu, Xiu-hong., Peng, Yi. Effect of post-harvest processing and extraction methods on total saponin content of Cyclocarya paliurus. Beifang yuanyi, 2014, p. 120-123.
  6. Li, Jun., Lu, Yuanyuan., Su, Xiaojian., Li, Fu., She, Zhigang., He, Xingcun., Lin, Yongcheng. A norsesquiterpene lactone and a benzoic acid derivative from the leaves of cyclocarya paliurus and their glucosidase and glycogen phosphorylase inhibiting activites. PLANTA MEDICA, 2008, vol. 74, no. 3, p. 287-289. DOI
  7. Xu, Ruiyong., Hong, Yanping., Shangguan, Xinchen., Yin, Zhongping., Jiang, Yan., Chen, Musen. Determination of total triterpene saponins in Cyclocarya paliurus (batal.) I1jinskaja by spectrophotometry. Jiangxi nongye daxue xuebao, 2007, p. 449-453.
  8. Shu, RG., Xu, CR., Li, LN., Yu, ZL. Cyclocariosides II and III: Two secodammarane triterpenoid saponins from Cyclocarya paliurus. PLANTA MEDICA, 1995, vol. 61, no. 6, p. 551-553. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue